Note: Ingredients listed on restricted chemical lists
EC/CAS
90063-37-9
Name of the chemical
Lavandula intermedia oil/extract; Lavandula angustifolia oil/extract (40)
Concentration
1 - 5
EC/CAS
204-589-7/122-99-6
Name of the chemical
2-Phenoxyethanol
Concentration
1 - 5
General Information
Version
1.1
Revision date
2025-03-04
Product name
ELYSIUM SPA SLEEP WELL PILLOW MIST SPRAY
supplier name
151 Products Limited
Emergency telephone
+44(0)161 839 5949, +353 1 809 2566, +353 1 809 2166
Icons in SDS
Company Information
company name
151 Products Limited
e-mail address of the competent person responsible for the Safety Data Sheet
Technical@151products.com
GHS Information
Signal word
Warning
Hazard Codes
Hazard statements (CLP)
H317
Hazard statements
Code
Statements
H317
May cause an allergic skin reaction
Section 2
SECTION 2: Hazards identification
According to Regulation (EC) No. 1272/2008 (CLP) Classification of the substance or mixture
Adverse physicochemical, human health and environmental effects
May cause an allergic skin reaction
Hazard pictograms
GHS07
Signal word
Warning
Contains
LAVANDULA ANGUSTIFOLIA OIL
Hazard statements
H317 - May cause an allergic skin reaction.
Precautionary statements
P102 - Keep out of reach of children. P103 - Read carefully and follow all instructions. P305+P351+P338 - IF IN EYES: Rinse cautiously with water for several minutes. Remove contact lenses, if present and easy to do. Continue rinsing. P302+P352 - IF ON SKIN: Wash with plenty of water. P333+P313 - If skin irritation or rash occurs: Get medical advice/attention. P101 - If medical advice is needed, have product container or label at hand. P501 - Dispose of contents, container in accordance with local/regional/national/international regulations. contents/container local authority guidelines.
2.3 Other hazards
Contains no PBT and/or vPvB substances ≥ 0.1% assessed in accordance with REACH Annex XIII The mixture does not contain substance(s) included in the list established in accordance with Article 59(1) of REACH for having endocrine disrupting properties, or substance(s) are not identified as having endocrine disrupting properties in accordance with the criteria set out in Commission Delegated Regulation (EU) 2017/2100 or Commission Regulation (EU) 2018/605 at a concentration equal to or greater than 0,1 %
2.1 Classification of the substance or mixture
Skin sensitisation, Category 1 H317 Full text of H- and EUH-statements: see section 16 Adverse physicochemical, human health and environmental effects May cause an allergic skin reaction. 2.2. Label elements
